Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Shionogi, Osaka University Set Up Joint Research Lab on Long COVID
March 4, 2024
- Shionogi Healthcare Launches OTC Version of Mucodyne
March 4, 2024
- Taiho Picks Up Rights to China Pharma’s Lung Cancer Drug
March 4, 2024
- Moderna Japan Taps Kazumasa Nagayama as New President
March 4, 2024
- Drugstore Chains Tsuruha and Welcia to Merge, Eye Definite Pact by 2027-End
March 1, 2024
- FoundationOne Approved as CDx for Retevmo in Japan: Chugai
March 1, 2024
- MSD Files Keytruda Plus Chemoradiotherapy for Cervical Cancer in Japan
March 1, 2024
- Otsuka, AN Ventures Hook Up on US$30 Million Investment
February 29, 2024
- Santen Seeks Japan Nod for Eye Drop Targeting Myopia
February 29, 2024
- Pfizer Submits Hemophilia Treatment Marstacimab in Japan
February 29, 2024
- Gilead Files Truvada for HIV Prevention in Japan
February 29, 2024
- Towa to Roll Out New WPP Strategy to Maintain NHI Prices of Key Medicines
February 28, 2024
- Takeda to Outsource Dengue Vaccine Production to India’s Biological E
February 28, 2024
- Mitsubishi Chemical Scraps Regenerative Medicine Unit
February 28, 2024
- Radicava’s Brazil Launch Set for February 29: Mitsubishi Tanabe
February 28, 2024
- Insmed Revs Up for Product Expansion in Japan, Arikayce Frontline Filing Set for 2026 with More to Follow
February 28, 2024
- Japan Drug Market Tops 11 Trillion Yen for 1st Time Driven by Oncologics: IQVIA
February 27, 2024
- Shionogi Seeks Japan Nod for Akili’s Therapeutic App for Kids with ADHD
February 27, 2024
- BMS Files Ulcerative Colitis Med Ozanimod in Japan
February 27, 2024
- Chugai Tapping Wearable to Objectively Gauge Pain, First Eyes Endometriosis Trial
February 26, 2024
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…